Clinical Trial

Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study examines whether routine treatment with semaglutide or tirzepatide, prescribed with lifestyle coaching in a real-world weight-management program, is associated with changes in biological age measured by the LinAge2 clinical aging clock over 6 months.
Protocol Amendment History 1 change
minor Completion pushed: 2026-12-31 -> 2027-12-31 2026-07-02
Trial Details
NCT Number NCT07444073
Lead Sponsor National University of Singapore
Collaborators: T3 Health PTE LTD
Conditions Aging, Obesity & Overweight
Enrollment 440 participants
Start Date 2026-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01